Jonathan Solomon, CEO, stated that the third quarter of 2025 was an important period for BiomX, highlighting that "we began the quarter strongly with first patient dosing in our Phase IIb trial, a ...

The National Bank of Ukraine (NBU) has applied a measure of influence to the Member of Parliament, the fifth President of Ukraine Petro Poroshenko in the form of a temporary, until the violation is ...

Thank you for standing by. My name is Tina, and I will be your conference operator today. At this time, I would like to welcome everyone to the Atai Beckley BPL-003 phase IIb open-label extension ...

NEW ORLEANS, LA—A single subcutaneous injection of a novel, small-molecule glycoprotein IIb/IIIa inhibitor administered at first medical contact in patients with suspected STEMI improves the patency ...

We are seeking a talented CLM IIB Developer to join our client's development team in London. You will be responsible for developing, maintaining, and supporting the Bank's internal and external ...

Cognitive outcomes observed in the oral blarcamesine 30 mg Precision Medicine cohort move toward normal aging profiles across validated clinical scales, supporting its relevance in early-stage ...

LONDON, United Kingdom, July 19, 2025 (EZ Newswire) -- iib East Africa, opens new tab has earned international recognition for its leadership in sustainable banking, securing three prestigious awards ...

Narcolepsy type 1 is a disorder of hypersomnolence caused by a loss of orexin neurons, which results in low orexin levels in the brain. In this phase 2, randomized, placebo-controlled trial, ...

LOS ANGELES − The expansion of the animal-style empire continues apace as California burger purveyor In-N-Out appears set to open at least seven new locations. Four of the new locations will be in the ...

Puzzling over the commonly confused "home in" vs. "hone in"? With our grammar guidance, you can home in on the correct usage. If your boss asks you to hone in on the best spot for a new retail outlet, ...

NEW YORK, April 05, 2025 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative ...